• CJC 1295 Peptide Synthetic Growth Hormone Releasing Peptide
  • CJC 1295 Peptide Synthetic Growth Hormone Releasing Peptide

CJC 1295 Peptide Synthetic Growth Hormone Releasing Peptide

CAS No.863288-34-0
Chemical Name:CJC1295
SynonymsCJC1295;----------;CJC-1295(2MG);CJC-1295(10mg);CJC-1295
All peptide products can be shipped from overseas warehouses in the United States and Canada.

  • CJC 1295 Peptide Synthetic Growth Hormone Releasing Peptide

Description

CAS: No.863288-34-0

Chemical Name:CJC1295

SynonymsCJC1295;----------;CJC-1295(2MG);CJC-1295(10mg);CJC-1295 Acetate;CJC-1295 CJC-1295;CJC1295 with out DAC;CJC1295 No DAC acetate;CJC-1295 Acetate without DAC;Peptides Bodybuilding cjc-1295

Molecular Formula:C152H252N44O42

Formula Weight:3367.89688

Product Description

Targeted Therapeutic and Research Applications

CJC-1295 peptide serves as a specialized solution for medical and research sectors focusing on growth hormone regulation. It is formulated to meet the requirements of pharmaceutical development and clinical research institutes, acting as a peptide api that facilitates endogenous growth hormone secretion. The product is particularly suited for endocrinologists, biotech researchers, and pharmaceutical manufacturers needing consistent, high-purity compounds for therapeutic protocols or experimental studies. Its precise dosing forms enhance controlled application in hormone deficiency treatments and growth hormone secretagogue investigations.

Advanced Chemical Specifications and Formulation Profiles

Manufactured under stringent quality controls, this fine chemicals supplier ensures that CJC-1295 863288-34-0 conforms to international standards with verified molecular formula C152H252N44O42 and formula weight 3367.89688. Available in both acetate and no-DAC variants, the peptide api’s formulations differ in half-life and activity duration, addressing specific pharmacokinetic profiles. Supplied in 2 mg and 10 mg vials, the product’s chemical stability and purity facilitate reliable research outcomes and therapeutic consistency. The product’s technical documentation substantiates its suitability for integration into complex peptide stacks or mono-therapy regimens.

Integration into Pharmaceutical and Biotech Industries

Within pharmaceutical manufacturing environments and biotech research laboratories, CJC-1295 peptide serves as a critical component for applications involving muscle anabolism, fat metabolism, and tissue recovery. Its use under strict compliance supports anti-aging medical research and hormone regulation therapies. The peptide api’s performance ensures synergy with other growth hormone secretagogues and compatibility with laboratory assay protocols. The product’s stable overseas warehouse distribution model further enhances supply chain efficiency for companies requiring ongoing peptide api procurement with assured quality and timely delivery.


Product Advantages

Design and Quality Assurance in Peptide Synthesis

The design of CJC-1295 863288-34-0 stems from a robust synthesis protocol that guarantees batch-to-batch consistency and molecular integrity. As a fine chemicals supplier, the manufacturing process incorporates advanced purification and quality control systems to ensure pharmaceutical-grade peptide api production. Variations including DAC and non-DAC forms provide tailored pharmacodynamics to meet diverse research and therapeutic needs. The structural adaptability and precise formulation support modular integration into existing pharmaceutical pipelines, enhancing scalable production and minimizing contamination risks inherent to peptide synthesis.

Enhanced Application Performance and Supply Reliability

CJC-1295 peptide provides superior functional performance through its extended biological activity and stable molecular profile, enabling enhanced usability in clinical and experimental settings. Delivered in validated dosage forms with rigorous lot testing, it offers researchers and pharmaceutical developers a dependable product that reduces variability and enhances experimental repeatability. The product’s supply is supported by strategically located overseas warehouses, facilitating prompt distribution and minimizing lead times. This stable supply chain model increases operational efficiency for active pharmaceutical ingredients suppliers and end-users, reinforcing workflow continuity in pharmaceutical research and manufacturing.


Use Scenarios

Growth Hormone Deficiency Treatment in Clinical Settings

In endocrinology clinics and specialized medical centers, CJC-1295 peptide functions as a key peptide api for addressing growth hormone insufficiency. The product’s regulated dosing and proven pharmacokinetics enable precise hormone regulatory protocols compliant with medical standards. Its contribution to stimulating endogenous growth hormone synthesis enhances patient outcomes in muscle mass retention and metabolic balance. Integration into therapeutic regimens follows strict clinical guidelines, with quality assured by the active pharmaceutical ingredients supplier’s adherence to regulatory requirements. This ensures the peptide api’s role as a reliable component in effective hormone replacement therapies.

Research and Development in Biotechnology Laboratories

In advanced biotech research laboratories, this research chemicals peptides category product supports experimental studies on anabolic signaling pathways and metabolic disorders. The availability in controlled dosage forms and variants with defined DAC profiles allows researchers to customize protocols for growth hormone secretion investigations. CJC-1295 peptide’s high purity and potency assist in generating reproducible data and facilitate peptide stack research. Its compatibility with laboratory synthesis and assay workflows enhances innovation in drug development projects. Procurement from a fine chemicals supplier with stable supply chains ensures uninterrupted research operations and consistent quality outputs.





FAQ

What versions of CJC-1295 do you offer for industrial use?

We supply CJC-1295 in both acetate and versions with or without DAC, providing options tailored to different activity durations. Our offerings include precisely measured vials of 2 mg and 10 mg, suitable for research and pharmaceutical applications involving peptide API.

How do you ensure the quality and stability of CJC-1295 during supply?

We maintain stringent quality controls aligned with international standards throughout our production and packaging processes. Our active pharmaceutical ingredients supplier status is backed by stable supply chains, including overseas warehouses in the US and Canada, ensuring product reliability and timely delivery.

Can you accommodate special packaging or dosage requirements for CJC-1295?

Yes, we offer CJC-1295 in multiple dosage forms such as 2 mg and 10 mg vials. We collaborate directly with clients to meet specific packaging or formulation needs, ensuring the peptide API meets defined project requirements within regulatory guidelines.

What logistical advantages do your warehouses in the US and Canada provide?

Our strategically located warehouses enable faster shipping and stable supply chains for customers in North America. This ensures that our research chemicals peptides, including CJC-1295, reach you promptly while maintaining product integrity through controlled storage conditions.